Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
AORT
TER
QRVO
From
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Tickers
AEO
AI
BHG
BIIB
Tags
Industrials
NVAX
Market News
From
Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
February 28, 2022
Tickers
BIIB
PFE
VTRS
Tags
VTRS
BIIB
PFE
From
MarketWatch
Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm
February 24, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
What Investors Can Learn From Biogen's Drug Approval That No One Wants
February 23, 2022
Tickers
BIIB
Tags
BIIB
Market News
Recent Press Releases
From
Motley Fool
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?
February 19, 2022
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
Tickers
AFRM
AGNC
AHI
ALGS
Tags
PEGA
RBBN
BMEA
From
Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
Tickers
BIIB
SAGE
Tags
depression
Trading Ideas
BIIB
From
Benzinga
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
Tickers
BIIB
BNTX
PFE
Tags
Market News
PFE
Biotech
From
Benzinga
3 Red Flags for Biogen's Future
February 16, 2022
Tickers
BIIB
Tags
Market News
Recent Press Releases
BIIB
From
Motley Fool
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Tickers
ALKS
AMGN
ATXI
AVNS
Tags
PACB
GBT
AMGN
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
VRTX
KYMR
CCCC
From
Motley Fool
What to Expect From Biogen's $2.3 Billion Shopping Spree
February 12, 2022
Tickers
AUPH
BHVN
BIIB
GS
Tags
BIIB
AUPH
Recent Press Releases
From
Motley Fool
2 High-Yield Dividend Stocks That Are Trading Near Their 52-Week Lows
February 10, 2022
Tickers
AMGN
BIIB
GILD
MMM
Tags
MMM
AMGN
RCUS
From
Motley Fool
2 Reasons to Buy Biogen, 1 Reason to Sell
February 10, 2022
Tickers
BIIB
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
February 08, 2022
Tickers
BIIB
UCBJF
UCBJY
Tags
Health Care
Contracts
UCBJF
From
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Tickers
ALKS
AMGN
AXSM
BIIB
Tags
Benzinga
QGEN
News
From
Benzinga
10 Biggest Price Target Changes For Monday
February 07, 2022
Tickers
ANTM
APD
BIIB
DIS
Tags
MTCH
EL
APD
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
News
NBIX
Benzinga
From
Benzinga
Biogen's Aduhelm Approval, Marketing Comes Under FTC, SEC Probes
February 04, 2022
Tickers
BIIB
Tags
Benzinga
General
Briefs
From
Benzinga
What 24 Analyst Ratings Have To Say About Biogen
February 04, 2022
Tickers
BIIB
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Analyst Ratings For Biogen
February 04, 2022
Tickers
BIIB
Tags
BIIB
Benzinga
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022
February 04, 2022
Tickers
ARBE
BIIB
BJ
BZFD
Tags
GTLB
WIT
SNBR
From
Benzinga
10 Biggest Price Target Changes For Friday
February 04, 2022
Tickers
AMZN
BDX
BIIB
BILL
Tags
PCTY
BILL
Benzinga
From
Benzinga
Biogen (BIIB) Q4 2021 Earnings Call Transcript
February 03, 2022
Tickers
BIIB
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus
February 03, 2022
Tickers
BIIB
Tags
Movers
Benzinga
Briefs
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
Tickers
ALPN
AMPS
ANIK
AXU
Tags
HON
BBSI
OP
From
Benzinga
Biogen: Q4 Earnings Insights
February 03, 2022
Tickers
BIIB
Tags
News
Earnings
Benzinga
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
GRTX
MRSN
ABMD
From
Benzinga
Recap: Biogen Q4 Earnings
February 03, 2022
Tickers
BIIB
Tags
BZI/Recaps
BIIB
Market News
From
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.